Investors in Venture Capita

115K is a Seed / Series A fund that invests in Fintech, Insurtech, Cybersecurity, AI and ESG. With €150m, we invest tickets from €0.5 to €5m. We have invested in 10 investments to date (Continuity, Garantme, Sésame-it, Carbo, Cashbee, Cosmian, Pono, Climateview, Numalis, Seclab) alongside the best funds in the market. We invest in France and Europe and aim to offer the best of both worlds between the professionalism of a VC (requirement/performance/investment practices in line with the VC market) and the strengths of a large group (La Poste, La Banque Postale, Docaposte, LBP Asset Management, CNP Assurance, etc.) to establish the fund as a benchmark player in France and Europe on these themes. La Banque Postale, with its subsidiaries including CNP Assurances, forms a leading European bancassurer, 11th in the Eurozone by balance sheet size. With 17,000 points of contact, we support more than 20 million individual and legal customers with a complete range accessible to all.

BlueOcean Ventures invests in early stage medical device and life science companies. Unlike other funds the four Founders of BlueOcean Ventures, Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz and Thomas Zehnder, have a long-standing track record in building, managing and coaching start-up companies. BlueOcean Ventures supports their portfolio companies with a large network of experts and industry contacts.

We are Agrinvest Commodities, an agricultural commodities brokerage company primarily engaged in soybean, corn, wheat, and dollar trading. Our company is located in Curitiba at Padre Anchieta Street, 2285. We also have branches in Sorriso - MT and Maringá - PR, as well as a branch in Geneva, Switzerland

Maximon empowers entrepreneurs to build impactful, science-based and scalable companies providing healthy aging and rejuvenation solutions. As a company builder, we identify the most promising business opportunities in the field of longevity and build companies from scratch. We provide proven structures, financing, and a unique and inspiring playground for entrepreneurs to build a longevity venture. With a team of globally successful entrepreneurs and venture investors, we have built a venture building process that bridges the gap between science and business.

Smart money for smart innovators"​ BAS, Business Angels Switzerland, is the most experienced Business Angel Club in Switzerland. We're a not-for-profit organization with chapters in Suisse Romande and in Zürich. We organize 20 events and 60 startup presentations per year. They lead to more than 10 yearly investments in all industries. Our eighty members and the startups like the familiar and friendly atmosphere of our events. The member list is not disclosed.

Privilège Ventures is a Swiss-based Venture Capital firm, authorized by the Swiss Financial Market Supervisory Authority (FINMA, www.finma.ch) as venture capital asset manager, investing in promising early-stage startups. With offices in Lugano and Zurich, we aim to support young founders on a mission to build the future. Our unique values derive from previous experiences as founders, entrepreneurs, operators and investors. We provide unceasing support, expertise, and valuable network access to help entrepreneurs forge ahead.

Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors.

We at La Maison are backed by a pool of outstanding investors, including entrepreneurs from diverse professional and geographical backgrounds such as the Dassault family, the David Weill family, Cointreau family, Carlo de Benedetti, Xavier Niel, Maurice Levy, and many others. Thanks to our unique entrepreneurial ecosystem, our DNA at La Maison is to invest in growth stage and late stage deals, as well as LBOs, with highly exclusive and qualified Venture Capital / Private Equity teams who have a tremendous track record. We aim to bring "smart money" to our investments. Since our creation, we have realized more than fifty investments, leading to approximately €700 million under management.

Convergence Partners is a European venture capital firm that invests in founders building high-impact companies in healthcare sectors with large unmet needs. The Convergence team actively drives the scale-up and internationalisation of its portfolio companies to Germany, China, US and India.

Science and technology are the emerging frontier driving the shift from sickcare to the new healthcare. Sickcare treats disease and manages symptoms.The new healthcare will proactively empower health through early and personalized care to prevent disease and extend healthy lifespan. At FORM Life Ventures, we believe that hard-nosed science will shape the future of healthcare by accelerating data-driven breakthroughs.

Épopée Gestion is an investment firm co-founded in 2020 by Ronan Le Moal and Charles Cabillic. Our mission is to develop the regional economy by providing long-term support to regional companies, mainly based in the West of France. We aim to "reinvest in the regions" and create regional champions through an inclusive investment ecosystem built around four complementary investment sectors: innovation and digital (West Web Valley I and Épopée West Web Valley II), SME/ETI transitions (Épopée Transitions I), sustainable real estate (Épopée Immo Rendement I), and infrastructure contributing to decarbonization. Our geographical area of ​​action is expected to gradually expand in the coming years.

We specialise in enterprise development and support management teams to optimise growth and profitability. We’re always on the lookout for talented entrepreneurs wanting to disrupt the status quo and push boundaries. The business areas we cover are technology, SaaS, e-commerce, markets, as well as business services. Driven by an unassailable belief in what we do, we help forward-thinking entrepreneurs flourish and make a positive impact on the future.